Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 35.7
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very weak growth
Data is available to registered users only
Data is available to registered users only
About
Carilex Medical, Inc. engages in the manufacturing of medical devices to prevent pressure ulcers and wound care management. Its products include medical grade air beds, chair cushion and negative pressure wound treatment machine. The company was founded on May 23, 2012 and is headquartered in Taoyuan, China.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is overvalued on EV/EBITDA, reasonably pric
Data is available to registered users only
Buy
Sell